Diclofenac Sodium Misoprostol Tablet, Delayed Release
Product Images NDC 75834-264

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium Misoprostol (NDC 75834-264). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (50 mg Bottle Label)

Packaging label for Diclofenac Sodium and Misoprostol Delayed-Release Tablets, USP containing 50 mg diclofenac sodium and 200 mcg misoprostol per tablet. The label indicates 60 tablets in a child-resistant container, manufactured by Nivagen Pharmaceuticals, Inc. Storage instructions and a contraindication warning regarding pregnancy are also shown.*

FDA Label Image

Principal Display Panel (75 mg Bottle Label)

Label for Diclofenac Sodium and Misoprostol Delayed-Release Tablets USP, 75 mg diclofenac sodium and 200 mcg misoprostol, oral tablet. The package contains 60 tablets in a child-resistant container and is manufactured for Nivagen Pharmaceuticals, Inc. Warning and storage instructions are included on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.